Drug Type Small molecule drug |
Synonyms PPA 27, PPA-27 |
Target |
Mechanism PP2A stimulants(Protein phosphatase 2A stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | US | 10 Apr 2022 |